1 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 26497877 | Phase I/II dose-escalation study of PI3K inhibitors pilaralisib or voxtalisib in combination with letrozole in patients with hormone-receptor-positive and HER2-negative metastatic breast cancer refractory to a non-steroidal aromatase inhibitor. | 2015 Nov | 1 |